Century Therapeutics’ headquarters are located at 25 N. 38th Street, 11th Floor, Philadelphia, PA 19104.

The Company was founded in 2018.

The Company is incorporated in Delaware.

Century Therapeutics completed its IPO on June 17, 2021.

The Company’s fiscal year ends December 31st.

The Company’s common stock is listed on the NASDAQ Market under the symbol “IPSC”.

The transfer agent and registrar for the common stock of Century Therapeutics’ stock is American Stock Transfer & Trust Company, LLC.

For questions about your stock please contact our transfer agent, American Stock Transfer & Trust Company, LLC.

To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, American Stock Transfer & Trust Company, LLC.

To transfer stock or replace a lost stock certificate, contact our transfer agent, American Stock Transfer & Trust Company, LLC.

The auditor for Century Therapeutics is Ernst & Young LLP located in Philadelphia, PA.

Legal counsel for Century Therapeutics is Goodwin Procter LLP, located in Philadelphia, PA.

To find out more about Century Therapeutics visit their webpage at www.centurytx.com.

Century Therapeutics’ press release archive can be viewed under the “News & Events” section of the “Investors” page and financial reports are available under the “SEC Filings” section located at our website: www.centurytx.com.

Century Therapeutics’ SEC Filings can be found on www.sec.gov and are also available under the “SEC Filings” section of the “Investors” page located at our website www.centurytx.com.

For a list of the Management team and Board of Directors, please visit the “About Us” tab of our website www.centurytx.com.

Please contact investor.relations@centurytx.com.